GLP-1 Drugs Reduce Depression, Boost Stress-Calming Gut Bacteria
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"GLP-1 Drugs Reduce Depression, Boost Stress-Calming Gut Bacteria" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include BioWorld News, Courthouse News, Medical Xpress and Fierce Biotech. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 134d ago.
Quick answers
Why is "GLP-1 Drugs Reduce Depression, Boost Stress-Calming Gut Bacteria" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (5)
- Microbiota modulates the antidepressant effects of GLP-1 analogues BioWorld News · 158d ago
- Guts may hold the key to happiness Courthouse News · 158d ago
- GLP-1s may alleviate depression through the microbiome, mouse study suggests Medical Xpress · 158d ago
- GLP-1s may combat depression through a mood-boosting gut microbe Fierce Biotech · 158d ago
- GLP-1 Drugs Reduce Depression, Boost Stress-Calming Gut Bacteria Neuroscience News · 158d ago
Topics
Related trends
Hundreds of children in England prescribed weight-loss jabs, figures show
Recent figures reveal hundreds of children in England are receiving GLP-1 weight-loss prescriptions.
Makers of obesity drugs hit back at claims of negative side effects
Makers of blockbuster weight loss drugs defend product safety amid mounting scrutiny over potential side effects.
Fairphone 6+ gets its first US carrier partner in Boost Mobile
Fairphone's modular, long-life Android smartphone secures its first U.S. carrier deal with Boost Mobile, expanding availability beyond direct sales.
DJ Khaled reflects on using GLP-1s in 90-pound weight loss journey: ‘I needed help’
DJ Khaled publicly details a 75-to-90-pound weight loss aided by GLP-1 medication Wegovy, sparking wide entertainment-media coverage.
‘Stop obsessing over eight hours’: New study says another sleep goal is just as key
A new study challenges the traditional eight-hour sleep rule by linking irregular sleep schedules directly to mental health conditions.
Ozempic and Zepbound users face 6 rebound risks after stopping, doctor warns
Internal medicine physician Dr. Frank Dumont warns that stopping GLP-1 medications like Ozempic and Zepbound carries six rebound risks, including rapid weight regain, loss of cardiovascular protection, and worsening mental health.